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Abstract 
 
 Due to the unique religious and cultural characteristics of Saudi Arabia, evaluating 
knoweldge and exploring attitudes toward cancer genetic tests (CGT) are important for 
bolstering currently underdeveloped CGT services. This cross sectional study was carried out 
in the form of a survey, targeting three different populations: physicians (n=105), cancer 
patients (n=102) and public participants (n=1087). The public cohort recorded a knowledge 
score (M=7.16, Mdn=7.00,SD=2.58) higher than patients cohort 
(M=4.98,Mdn=5.00,SD=2.95). Both patient and public participants expressed interest in 
CGT. Willingness to undergo CGT correlated with high knowledge in the public cohort (r 
(1083)= .12, p<.001), while the patient cohort was only willing in the context of a positive 
family history of cancer (r (100) =.29, p<0.01). Attitudes toward CGT were not correlated 
with religiosity, fear of stigma, or privacy in the public cohort. Out of these variables; 
religiosity was coorelated with positive attitude toward genetic services in patient cohort (e.g. 
willingness to see a genetic counselor (Chi-square(4)=10.33, p<.05). Despite the 
unavailability of cancer genetic clinics in the area; 79.1% of physicians reported 
expectations in increasing the number of patients who will be interested in CGT, 63.8% 
strongly agreed that patients should not undergo CGT without counseling, and 100% said 
they would refer some or all of their applicable patients should a clinic open up. Physicians’ 
self-reported qualifications, attitudes toward CGT, and confounding factors were also 
investigated, and showed significant amounts of uncertainty regarding many aspects of CGT 
amongst the respondents; including clinical utility, cost effectiveness, discrimination and 
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patient confidentiality. To conclude, there is an overall positive attitude toward cancer 
genetic services in Saudi society. Public health actions to enhance cancer genetic services 
should be implemented to recognize and improve care for high-risk families. 
Keywords: Cancer genetic counseling, genetic counseling, Saudi Arabia, attitude. 
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Background 
Cancer incidence in Saudi Arabia has remained relatively steady with approximately 2,500 
new cases diagnosed annually in Riyadh (Tumor registry, 2012). In 2011, the most frequent 
cancers in males were colorectal, leukemia & Non-Hodgkin’s lymphoma. In females, breast 
cancer, thyroid cancer and leukemia were the most common (Tumor registry, 2012). Public 
awareness of cancer and cancer related care is low in the kingdom (Amin et al, 2009; 
Ravichandran et al, 2010; Ravichandran et al, 2011; Khayaat & Ibrahim 2013; Eldeek et al, 
2014).   
The nature of Saudi society may affect the use of genetic tests and counseling services. 
Certain social norms around religiosity, sharing of information, and stigma could dictate 
practice as it pertains to uptake of genetic services and testing. Our study did ask 
participants in the public and patient cohorts to self-report their level of religiosity; 
however the researchers did not provide set definitions around the categories for the 
participants to identify (such as mosque attendance and prayer rituals).  Previous studies in 
Saudi Arabia either investigated one aspect of attitude and/or knowledge toward cancer 
genetic services, or focused on one population. (Amin et al, 2009; Milaat, 2000; 
Ravichandran et al, 2011).   
Ravichandran, Mohammed and Al-hamdan (2010) found that younger, single females had a 
higher overall knowledge about cancer when compared to their counterparts. Additionally, 
knowing someone with cancer or having personal experience with cancer screening (e.g. 
mammogram, occult blood test, breast exam or PAP smear) were also associated with 
KNOWLEDGE AND ATTITUDE OF CANCER GENETICS IN SAUDI ARABIA    5 
increased knowledge about cancer. In a different study (Ravichandran, Al-hamdan and 
Mohamed, 2011) about attitudes and behaviors of Saudis with respect to cancer prevention, 
95.8% of participants acknowledged the importance of early detection. 55.1% stated they 
would definitely participate in a cancer detection program in the future, 32.1% were less sure 
and 12.8% said they would not. When surveyed on their current behaviors, only 23.1% 
reported that they administered self-breast exams, 14.2% went for clinical breast exams and 
8.1% had undergone a mammogram. Barriers to seeking clinical breast exams among women 
include cultural traditions about modesty and being examined by a male physician, shortage 
of clinics specializing in women’s health, a lack of female physicians at all levels of care, and 
belief among young women that breast exams are for the elderly (Amin et al, 2009).   
Even among family members of cancer patients, overall knowledge of cancer was low. 
Eldeek et al. (2014) surveyed 846 healthy individuals who attended an outpatient cancer 
clinic in Jeddah, Saudi Arabia with their sick relatives. While genetics and diet were 
identified by a large percentage of participants (44.9% and 30.1% respectively) as causes of 
cancer, other unfounded factors, such as envy (26.9%), black magic (17.6%) and sadness 
(12.8%) were also mentioned. 32.5% of participants either did not know or were unsure if 
cancer was contagious. As previously established, a lack of public awareness is a barrier to 
cancer prevention and care. In a cross sectional study of the general population, 65.1% of 
participants attributed their knowledge about cancer to information provided by 
radio/television, 55.4 % cited friends/relatives and 52.9% pointed to newspapers/magazines. 
While 29.4% mentioned their physicians and 7.9% mentioned primary healthcare providers 
as source of knowledge (Ravichandran et al, 2011).  
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Clinical genetics in Saudi Arabia is a growing field, with approximately 30 board certified 
clinical geneticists (Alkuraya, 2014) and 10 genetic counselors (Qari et al, 2013). A majority 
of the physicians were trained in clinical genetics abroad; however a domestic program was 
recently developed and accredited (Alkuraya, 2014). Four of the genetic counselors 
graduated with a Master’s-level degree from the United Kingdom and one (non-Saudi) 
graduated from the United States of America. The remaining five counselors graduated with 
a high diploma-level degree from the recently established genetic counseling training 
program at KFSH&RC (Qari et al, 2013). 
With hereditary cancer accounting for 5-10% of all cancer case, cancer risk counseling has 
grown rapidly in recent years to become a major area of specialization within genetic 
counseling (Mendes, 2013). However, it is still immature in Saudi Arabia, regardless of the 
development of different oncology centers. As of now, there is no cancer genetic counseling 
clinic in Saudi Arabia; however, some health institutes have expressed interest in having this 
service as part of the services provided to their patients. (Qari et al, 2013). Acceptance of 
cancer genetic counseling services depends upon the awareness, attitudes, and social 
influences (i.e. ethics, religion, economics, culture, law, education, etc.) of both physicians 
and the public. (Kinney et al, 2010; Bando, 2013).     
A cross sectional study (Amin et al, 2012) of 599 women in the Eastern Province found that 
almost 20% of participants believed themselves to be at higher risk for breast cancer than 
their peers. With regards to genetic testing for breast cancer genes, knowledge was highest 
among employed, college educated women between the ages of 30 and-40. 42.8% of women 
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expressed a general interest in undergoing genetic testing for breast cancer genes, while 
11.9% would undergo testing if certain conditions were met, such as no fee, geographic 
convenience, physician recommendation, reputable laboratory, family/husband consent and 
pretest counseling to alleviate anxiety.  
At this time no studies have been performed to broadly assess cancer genetics knowledge, 
attitudes and behaviors among the general public, cancer survivors or physicians in Saudi 
Arabia. The goals of this study are to: 1) get a better understanding of how cancer genetic 
services are perceived in the general public, among cancer survivors and among physicians; 
2) to measure physician knowledge and attitude toward genetic counseling services, 
considering the influential role of healthcare providers in motivating patients to receive 
genetic counseling and risk assessment; 3) to explore the acceptance of genetic counseling 
services in Saudi soceity, as it relates to awareness, attitudes, and social influences (i.e. 
ethics, religion, economics, culture, law, education, etc…) of both physicians and the public.  
Materials and Methods 
This is cross sectional study carried out in the form of a survey. This study survey was 
directed toward three different populations: physicians, cancer patients and the public 
(physicians who had been diagnosed with cancer were instructed to respond as cancer 
patients). Participants were recruited using email list serves from the following organizations: 
Saudi Oncology Society (SOS), Saudi Cancer Society, Saudi American Cultural Mission 
(SACM) and Hospitals intra-email systems to reach physicians (National Guard Health 
Affairs, King Fahad Medical City and Security Forces Hospital). Participation in the online 
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anonymous survey was voluntary.   
The three surveys were designed based on a comprehensive review of the literature. The 
survey used to collect information from the respondent consisted of four broad categories: 1) 
demographics and personal information; 2) knowledge of cancer; 3) knowledge of cancer 
screening; and 4) attitude toward genetic counseling and early detection/screening programs. 
The inclusion criteria for the study was: 1) Saudi nationality; and 2) Age of 18 years or older.  
This study was approved by the King Abdul-Aziz Medical City in Riyadh, Saudi Arabia on 
August 15, 2013, with a renewal issued on August 21, 2014, the Julia Dykman Andrus 
Memorial’s Institutional Review Board on September 30,2013, with a renewal issued on 
October 28, 2014, and King Fahad Medical City in Riyadh, Saudi Arabia on March 1st, 2014.  
Characteristics of the study population were summarized as frequencies, means and standard 
deviations (SD). The association between two categorical variables (i.e.:  demographic 
parameters, respondent’s knowledge and/or religion analysis) was evaluated by a Chi square 
test and cross tabulation. Multiple logistic regression analyses, using a backward stepwise 
elimination procedure, were performed to examine the potential impact of the variables. All 
the explanatory variables were calculated using the SPSS 16.0 software program. 
The measurement of participants’ knowledge was scored based on giving one point to correct 
answers and zero points to incorrect or uncertain (don’t know) responses. A correct response 
was evaluated based on current literature. The knowledge score was computed by totaling the 
number of correct answers. The expected maximum total score was 15 points. Then the score 
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was recoded as a dichotomous variable - low and high - with an arbitrary cut off point of 
50% correct answers or more, to evaluate knowledge levels. Continuous variables were 
grouped in to ordinal categories to facilitate inclusion in the multiple logistic regression 
analysis. Analysis of variance (ANOVA) used to measure knowledge scores with different 
independent variables. 
Results 
Physicians Survey 
A total of 516 physicians from different specialties were invited to participate in the study, of 
whom 105 (20.35%) returned a completed questionnaire. 15.4% of respondents were 
oncologists. The other specialities represented included gynocologists, surgeons, and family 
medicine practitioners. 91.4% worked in a government hospital, 4.8% in private practice 
and 3.8% were self-employed. 38.1% of physicians in our sample ordered predictive genetic 
testing for cancer in the previous year. (Appendix A-Table-1) 
 
When physicians asked if they felt qualified to recommend genetic testing themselves, 
34.3% felt they were very well qualified, 38.1% were somewhat qualified, 19% were not 
very well qualified, 4.8% reported they were not qualified at all, and 3.8% were not sure.  
Physicians who considered themselves more qualified to recommend genetic counseling 
to their patients ordered genetic testing for inherited cancer susceptibility more often (Chi-
square (2) = 20.97, p < .001). Almost all, 96.6%, of those who thought they were not 
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qualified or were unsure of recommending genetic tests had not ordered genetic testing for 
inherited cancer susceptibility.  
 
Feeling qualified to recommend genetic testing for inherited cancer susceptibility was 
positively correlated with having ordered the genetic testing for patients (r (102) = .40, p < 
.001) and with having referred a patient to another health care facility for genetic testing (r 
(100) = .24, p< .01). Feeling qualified was positively correlated with agreeing that there is 
strong scientific evidence to support the use of genetic testing in predicting recurrence risk 
and benefit from chemotherapy (r (103) = .27, p < .01). Feeling qualified was also correlated 
with agreeing that the negative result can help in reassuring the patient and their family 
members that cancer is definitely not inherited (r (103) = .24, p < .01), agreeing that patients 
should not undergo testing unless they get genetic counseling about the risks, benefits, and 
consequences of the test (r (103) = .24, p< .01) and agreeing that it is difficult to insure that 
the patients’ test results will remain confidential (r (103) = .17, p < .05). Referring a patient 
to another health care facility for testing was positively correlated with agreeing that there is 
strong scientific evidence to support the use of genetic testing in predicting recurrence and 
risk and benefit from chemotherapy (r (100) =n.23, p < .01), and with thinking that genetic 
testing services are not readily available or difficult to access (r (99) = .19, p < .05).  
 
Three questions on clinical utility concerned the issues of risk analysis, cost-effectiveness, 
accuracy and availability of guidelines. Almost 40% of physicians believe that the risk of 
cancer in patients who have a positive genetic test is not clear, while 55.3% disagreed with 
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this statement, and 4.8% were unsure. More than one-third of physicians believe that 
genetic testing of patients with family history is not cost-effective (11.4% strongly agree, 
and 24.8% somewhat agree), while 36.2% strongly disagree, and 7.6% were unsure. 
Almost 39% of physicians indicated that genetic tests for cancer susceptibility have too 
many false positives, false negatives, or ambiguous results and 26.7% of physicians were 
unsure.  
 
Physicians who more frequently asked new patients to provide a family history of cancer 
among first degree relatives and those who asked more frequently about second degree 
relatives were more likely to agree that there is strong scientific evidence to support the use 
of genetic tests in predicating the recurrence risk and benefit from chemotherapy (r (102) = 
.33, p< .001 and r (102) = .20, p < .05). They were also more likely to request genetic 
testing to enable them to recommend appropriate management strategies to their patients, 
which include intensive surveillance, prophylactic surgery, or chemoprevention (r (102) = 
.19, p< .05 and r (102) = .17, p < .05). Additionally, they were more likely to agree that 
patients should not undergo testing unless they underwent counseling about the risks, 
benefits, and consequences of the test (r (102) = .26, p< .01). 
 
Three questions concerned the issues of insurance discrimination for patients with positive 
test results, health insurance coverage for genetic tests for cancer susceptibility, and 
confidentiality of test results. 46.7% of all physicians thought that patients with positive 
genetic test results were at risk for insurance discrimination. 32.3% disagreed with this 
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statement, and 21% were unsure. Almost 40.9% of physicians believed that ordering genetic 
tests for cancer susceptibility was influenced by coverage of their patient’s health insurance 
plans, although 32.3% said it is not important factor when they order genetic testing. Almost 
half of physicians (45.8%) thought that it was difficult to ensure the confidentiality of patient 
test results.  
 
38.1% of physicians reported that they expected the number of their patients who undergo 
genetic testing for cancer susceptibility to increase substantially and more 41% agreed that 
the number would be somewhat increasing during the next 5 years. Two access questions 
covered the issues of genetic counseling and the availability of genetic testing services. More 
than 63.8% of physicians strongly agree that patients should not undergo testing unless they 
obtain counseling about the risks, benefits and consequences of the test. 24.8% somewhat 
agree with this statement, and 3.8% are not sure about this. 
 
On exploring factors that influence recommending genetic testing for hereditary cancer 
syndromes, 80% reported that the patient’s attitude and also his/her family's attitude is 
important to somewhat important in recommending such tests. On the other hand, about 
17.1% thought that the attitude toward this service was not important, and 1.9% were 
unsure. In addition, physicians were asked if they do not support cancer genetic testing 
because of concerns regard psychological impact of cancer genetic testing on patients; 41.9% 
agreed, compared to 50.5% who disagreed, 7.6% were unsure. Although 96.2% of 
physicians recognize the need for guidelines for genetic testing for inherited cancer 
KNOWLEDGE AND ATTITUDE OF CANCER GENETICS IN SAUDI ARABIA    13 
susceptibility, only 62.37% of them reported being very interested in receiving continuing 
medical education courses in genetic risk assessment for cancer susceptibility. And 8.91% of 
physicians who agreed on the importance of guidelines said they are not interested in such 
training.  
 
Public and patients surveys:  
A total of 1187 participants completed the survey; 1085 members were general public and 
102 were cancer survivors. (Appendix B -Table 2) Amongst the public participants, there 
were 640 males (59%) and 445 females (41%). Nearly 40% of public participants were 18-24 
years old, 53% were between 25 and 50 years of age, and 7.7% were above 50 years of age. 
The median age was 32. Patients were voluntarily participating in this study. The majority of 
patients were females 59.8%, while 40.2% were males. Nearly 8.8% of patients were 18-24 
years old, 61.7% were between 25 and 50 years of age, and 29.4% were above 50 years of age. 
The median age was 41.9 years.  
 
Relatives with cancer and exposure to testing 
Nearly, 58.7% of the public cohort reported having a relative with cancer; the majority 
(79.74%) were first-degree relatives. However, public experience with genetic testing was 
limited to only 17.3%, and 13.3% of the cohort was aware that their friends or family members 
had ever received cancer genetic testing. The same percentage of respondents from the patient 
cohort (58.8%) reported having a relative with cancer. Patient experience with genetic testing 
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in general was again limited to 11.8%, while 16.7% of patients were aware that their friends or 
family members had ever recieved cancer genetic testing. 
 
Public & Patient reported knowledge 
On asking public participants to rate their knowledge level in genetics, most (60.6%) 
reported knowing the same as most people, and approximately one fifth (21.1%) reported 
knowing more than most people about genetic testing; 18.4% reported knowing less than 
others or nothing at all about genetics. In addition, more than half of the patients (56.9%) 
rate their knowledge as the same as most people. Fewer patients (12.7%) reported knowing 
more than most people about genetics, and 21.6% reported knowing nothing at all about 
genetics.  
 
Public & Patient knowledge index 
A knowledge index is created by assigning one point for every question answered 
correctly and summing the scores. The mean total knowledge score for the public was 7.16 
out of 15 (SD=2.58), the median was 7.00. On the other hand, the mean total knowledge score 
for patients was 4.98 out of 15, the median was 5 out of 15 (SD=2.95). This finding 
consisted with a previous study from Saudi Arabia, where patients scored lower knowledge 
scores compared to doctors, nurses and public participants regarding GI cancers. (Parvez et 
al., 2004). Out of the 15 knowledge-related items, only two public participants answered all 
knowledge questions correctly, and only 19.3% answered 10 of the 15 questions correctly. 
No one in the patient cohort answered all knowledge questions correctly and only 3 people 
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(2.9%) answered 10 questions correctly. Almost half of responders answered correctly that 
breast and lung cancers are multifactorial in nature (44.9% and 46.2%, respectively). The 
question most often answered incorrectly in both focused groups was whether spina bifida 
was caused by genetic factors, environmental factors, or both. Only 13.4% of public and 
6.9% of patients answered correctly. (Appendix C- Table 3) 
 
Public and patient correlations for knowledge index 
In public cohort, only four demographic variables were significantly correlated with the 
knowledge index. These were income (r (1083)= .58, p<.001), being female (r (1083)= .26, 
p<.001), education (r (1083)= .23, p<.001) and age (r (1083)= .15, p<.001). In the patient 
cohort, significant correlations with knowledge scores were found for three demographic 
variables: education (r (86) = .36, P<0.001), gender (being female) (r (100) .33, p<.001), and 
income (r (99),  =.22, p<.05). Knowledge was not correlated with age, region, city, marital 
status, having children, or level of religion.  
 
There was a significant correlation between knowledge and learning about the genetic 
explanation of cancer from their own experience with cancer (r (100) = .32, p<0.01), having 
friends or family members who had a hereditary cancer disease (r (100) = .25, p<0.01), 
having family or friends who had a genetic test (r (100) = .24, p<0.05), not refusing a cancer 
genetic test because of stigma (r (100) = .22, p<0.05) by their doctors. Knowledge was 
related to perceiving genetic tests for cancer to be accurate (r (100) = .27, p<0.01). 
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Figure1: Is genetic testing for hereditary cancer syndrome accurate? 
  
 
Public and patient predictive genetic testing for cancer 
Several confounding factors were assessed in the study regarding genetic testing. The 
majority of participants, patients and public, were interested in predictive cancer genetic 
testing in general, 72.5% (SD=0.737) and 58.4 %(SD=0.73) respectively. Both focused 
groups that declined testing, expressed further interest in testing if there was a family history 
indicating a need for testing. However, in the absence of treatment, the interest in testing 
dropped to half in the case of public respondents and almost a quarter in the case of patients. 
Participants were asked whether or not they would refuse genetic testing due to perceived 
stigma. (Figure 2) 
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Figure 2: Participants view on refusal genetic testing due to perceived stigma. 
 
A substantial majority of public and patient participants (74.6% and 84.3%) agreed that 
physicians are entitled to share genetic test results with family members, even if it violated 
the test candidate's privacy. However, 75% of respindents perceived that secrecy could be a 
barrier for cancer genetic testing. While in public population, knowledge was significantly 
related to willingness to undergo genetic testing for risk of developing cancer before the age 
of 65 (r (1083)= .12, p<.001). Knowledge was also related to perceiving genetic tests for 
cancer to be accurate (r (1083)= .11, p<.001). Patients knowledge on the other hand was not 
related to willingness to undergo genetic testing about person’s risk for developing cancer 
before age of 65 but was significantly related to wanting to test for a higher cancer risk if 
they had a family history (r (100) = .29, p<0.01).  
 
Public and patient attitude about genetic counseling 
Overall, public (62.4%) and patient (70.6%) respondents were interested in cancer genetic 
counseling services, compared to 18.6% of public and (12.73%) of patients who were 
definitely not interested in this service. Interestingly, 24.75% of public who declined genetic 
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counseling service considered visiting a psychologist if their cancer genetic test result 
showed a higher predisposition to develop cancer. While patients didn’t express significance 
interest in visiting a psychologist if their cancer genetic test result showed higher 
predisposition to develop cancer. 
 
The effective of religiosity 
Crosstabular analysis was done between the level of religiosity of the person and their 
willingness to undergo genetic testing, willingness to see a genetic counselor, willingness to 
see a psychologist, willingness to share genetic cancer information with relatives, and 
refusing a genetic test because of stigma. In public population, level of religiosity was not 
significantly associated with any of the above variables. However, in the patient population, 
level of religiosity was significantly associated with willingness to see a genetic counselor 
(Chi-square (4) = 10.33, p < .05). 81.0% of those with “average” religiosity would see a 
genetic counselor, and 73.6% of those with a conservative background would see a genetic 
counselor, and 55.6% of those with a strict religious background would see a counselor.  
 
Level of religiosity was also significantly associated with refusing to take a genetic test 
because of stigma  (Chi-square (4) = 11.40, p < .05). While 66.7% of those with “average” 
religiosity would not refuse a test because of stigma, and 73.6% of those with a conservative 
background would not refuse a test because of stigma, only 51.9% of those with a strict 
religious background would not refuse a test because of stigma. For patient cohort, level of 
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religiosity was not willingness to see a psychologist, or willingness to share information with 
relatives.   
 
The patient experience is summerized in figure 3.  
Figure 3: Patient experience: 
 
On investigating the reasons behind interest in genetic testing for hereditary cancer 
syndrome; the main reason for both cohorts was as it may help treatment.  
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Figure 4: Reasons behind interest in genetic testing for hereditary cancer syndrome. 
 
 
Discussion 
The present study is the largest observational cancer genetic services study in Saudi Arabia to 
date. In the present study, both patient and public participants expressed interest in 
genetic testing for hereditary cancer syndrome, 72.5% and 58.4% respectively. This was 
similar to previous studies where almost half (42.8%) of the participants expressed interest 
in genetic testing for breast cancer. (Amin et al, 2012). In the public cohort; high income, 
being female, higher education and age were the variables that had the highest correlation 
with knowledge index. In the patient cohort; higher education, being female, and high 
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income had significance correlations with knowledge scores. In this study, higher 
knowledge scores in the public cohort correlated with a greater willingness to undergo 
genetic testing overall. In the patient cohort, higher knowledge scores were correlated 
with a greater willingness to undergo genetic testing only in the context of a positive 
family history of cancer.   
 
Predicting uptake of genetic testing is a complicated proposition. Sweney et al. (2014) 
completed a qualitative systematic review of the literature in which they analyzed 115 
studies in an attempt to identify what factors, if any, influenced people’s decision to 
pursue testing. Sweeny categorized their findings into subjective (perceived risk of 
disease, disease- specific worry, perceived control, perceived disease severity, perceived 
benefits to testing, perceived barriers to testing, subjective norms, attitudes toward testing, 
knowledge and perceived risks of testing) and objective (family health history, personal 
health history, general health motivation, monitoring, positive outlook, discomfort with 
uncertainty, decisional preference, gender, education, employment status, income, age, 
marital/parental status, and religiosity) predictors. The researchers concluded that people are 
more likely to undergo genetic testing when they perceive the benefits of the testing to be 
high and the risks to be low; when the tests are accessible and when the testing is 
regarded in a positive light.  Knowledge did not prove to be a consistent predictor of 
uptake.    
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79.1% of physicians in this study reported they expected an increase in the number of 
patients who will be willing to undergo genetic testing for cancer. The reported interest 
captured by this study refutes previous studies who propose that the high rate of interest 
among female participants may not adequately reflect the genuine demand for testing, but 
instead a generic interest in modern laboratory procedures (Bruno et al, 2004) or 
misunderstanding of the impact genetic testing can have on breast cancer risk analysis 
(Amin et al, 2012). 
 
More than half of physicians (63.8%) strongly agree that patients should not undergo testing 
unless they obtain counseling about the risks, benefits and consequences of the test. On the 
availability of facilities that can provide genetic counseling and testing for inherited cancer 
susceptibility in the geographic area from which you draw your patients, 45.7% of 
physicians reported there is available facility, 24.8% said there is no available facility and 
28.6% were unsure of the availability. 12% of those who referred thier patient to seek 
genetic testing referred them to genetic counselors, while 56.25% referred them to 
geneticists. This finding is consistent with a 2012 study of physician attitudes toward genetic 
counseling services in Pakistan (Ashfaq et al, 2012). While there are no genetics clinics in 
the area, 100% of the physicians surveyed would refer some or all of their applicable patients 
should one open up. 41.9% of physicians reported concerns regarding the psychological 
impact of cancer genetic testing on patients. This is exactly the area where genetic 
counselors can be best utilized.   
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Genetic counseling is defined as “the process of helping people understand and adapt to the 
medical, psychological and familial implications of genetic contributions to disease” (Resta 
et al, 2006). There was a significant amount of uncertainty surrounding many aspects of 
cancer genetic testing amongst the physician respondents; including clinical utility, cost 
effectiveness, discrimination and patient confidentiality. 28% of respondents reported that 
they were unqualified to recommend genetic testing. 90.5% reported that they are interested 
in received continuing education in genetic risk assessment and testing for inherited cancer 
susceptibility; and 96.2% felt there is a need for physician guidelines to inform practice. 
Consequently, this may affect cancer risk communication and the decision making process 
and/or medical management for cancer patients. (Schneider, 2011) 
 
62.4% of public participants were interested in cancer genetic counseling. Of those who 
would not see a genetic counselor, 24.75% considered visiting a psychologist if their cancer 
genetic test result showed higher predisposition to develop cancer. 70.6% of patient 
participants were interested in genetic counseling. Those who declined genetic counseling 
didn’t express significance interest in visiting a psychologist if their cancer genetic test result 
showed higher predisposition to develop cancer. The decision to outright decline genetic 
counseling services or the preference for a psychologist may indicate a low understanding 
of the role of a genetic counselor among public cohort. The slightly higher acceptance of 
genetic cousneling services in the patient cohort may reflect a greater appreciation for the 
role, especially if their oncologist did not discuss genetics as part of their care. Additional 
education is required for both populations as genetic counseling improves knowledge of 
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cancer genetics and uptake of testing without an adverse effect on cancer-specific worry, 
general anxiety, distress, and depression. (Braithwaite et al, 2004)  
 
Previous studies tried to connect a relationship between religiosity and attitude toward 
genetic testing. While some of the studies indicate negative correlation (Botoseneanu et al, 
2011, Bowen et al, 2003), other studies show the opposite (Warner, Curnow, Polglase, & 
Debinski, 2005). This is consistent with Sweeny et al. (2014) conclusions that socio-
demographic information and religiosity were objective predictors that were not consistent 
and sometimes contradictory in terms of testing uptake.     
 
With regard to stigma and privacy, our study found that more than 84.4% of the patient 
respondents and 57.7% of the public respondents thought that doctors are entitled to share 
genetic tests results information with relatives if there is impact on their lives. The patient 
respondents were specifically asked about willingness to share their genetic results with 
relatives, given their experience; 59.8% were definitely willing to share, 24.5% refused 
and 15.7% did not know if they will share their information. The next generation of 
physicians in Saudi Arabia also embraces the idea of disclosure (Al-Amri, 2011), 
hopefully helping to alleviate some of the stigma previously discussed. 
 
Earlier study suggested poor cancer risk communication on the behalf of physicians with 
their patients, (Kelly et al, 2009) present study findings regard patient experience (Figure 3) 
support these findings. Overall, current study results demonstrate a seemingly harmonious 
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picture between physician’s self-reported qualifications and patient experience. Review the 
hereditary component of cancer diagnosis with patients not only considered a professional 
role (Worthern et al, 1999), but empower the patient with necessary information in order to 
maintain their autonomy (Schneider, 2011) 
 
Conclusion 
In conclusion the study found a broad interest for and positive attitude towards genetic 
services for hereditary cancer syndromes in Saudi Arabia. Greater education is needed across 
all populations. Further areas of research include some barriers to access (perceived or real) 
to genetic services as well as further exploration into factors that influence uptake in Saudi 
society as the vast majority of this data exists for patients of Western origin.  
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Appendix 
 
A. Physician demographic: Table-1 
  Frequency % 
Nationality    
 Saudi 63 60% 
 Non-Saudi 42 40% 
Affiliation with academic 
institution 
   
 Yes 68 64.8% 
 No 37 35.2% 
Prcatice management    
 Govermental  96 91.4% 
 Commercial 
owned 
5 4.8% 
 Self-employeed 4 3.8% 
Total phyiscian in this practice    
 1 3 2.9% 
 2-5 21 20.0% 
 6-10 22 21.0% 
 11-15 15 14.3% 
 16-30 16 15.2% 
 >30 28 26.7% 
Number of patients per week    
 <10 40 38.1% 
 10-20 34 32.4% 
 21-30 14 13.3% 
 >30 17 16.2% 
Approximate percentage covered 
by health insurance plans 
   
 None 44 41.9% 
 1-9% 13 12.4% 
 10-19% 3 2.9% 
 20-29% 4 3.8% 
 30-49% 7 6.7% 
 >50% 34 32.4% 
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B. Socio-demographic data for patient and public: Table-2  
  Public Patient 
  Frequency % Frequency % 
Number of participants  1085  102  
Age      
 18-24 426 39.26% 9 8.82% 
 25-29 292 26.91% 14 13.73% 
 30-39 243 22.40% 23 22.55% 
 40-49 84 7.74% 26 25.49% 
 50- Above 39 3.59% 30 29.41% 
Gender      
 Male 445 41.01% 61 59.80% 
 Female 639 58.89% 41 40.20% 
Education level     
 < High school 26 2.40% 20 19.61% 
 High school 278 25.62% 24 23.53% 
 Bachelor 489 45.07% 33 32.35% 
 Post-graduate 165 15.21% 7 6.86% 
 Bachelor/Medical 89 8.20% 2 1.96% 
 Other 35 3.23% 15 14.71% 
Province of origin      
 Central  630 58.06% 69 67.65% 
 East  105 15.68% 7 6.86% 
 West  167 15.39% 7 6.86% 
 South  121 11.15% 12 11.76% 
 North  61 5.62% 6 5.88% 
Marital status      
 Never married 614 56.59% 21 20.59% 
 Married 425 39.17% 73 71.57% 
 Widowed 11 1.01% 2 1.96% 
 Separated  7 0.65% 1 0.98% 
 Divorced 27 2.49% 5 4.90% 
Children     
 Yes 374 32.97% 71 69.61% 
 No 111 8.96% 22 21.57% 
 Do not show  600 52.04% 9 8.82% 
Employment status     
 Student 468 43.13% 9 8.82% 
 Un-employed  143 13.18% 36 35.29% 
 Employed 448 41.29% 42 41.18% 
 Retired 25 2.30% 14 13.73% 
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Employed      
 Self-employment 72 6.64% 6 5.88% 
 Office work/Admin 165 15.21% 12 11.76% 
 Education 135 12.44% 14 13.73% 
 Military 57 5.25% 1 0.98% 
 Health professionals 114 10.51% 6 5.88% 
 Engineering 22 2.03% 3 2.94% 
 Not employee 383 35.30% 42 41.18% 
 other 111 10.23% 16 15.69% 
 Not answer 25 2.30% 2 1.96% 
Income      
 < 2999 SR 164 15.12% 9 8.82% 
 3000 – 5999 118 10.88% 10 9.80% 
 6000-9900 185 17.05% 16 15.69% 
 > 10,000 277 25.53% 26 25.49% 
 No salary 340 31.34% 41 40.20% 
Religiosity     
 Very religious 118 10.88% 27 26.47% 
 Moderate religious 532 49.03% 53 51.96% 
 Low religious 400 36.87% 21 20.59% 
 Non religious  34 2.99% 0 0.00% 
Family history of cancer     
 No family history 328 30.23% 42 41.18% 
 First degree relative 129 11.89% 16 15.69% 
 Second degree relative 305 28.11% 29 28.43% 
 Third degree relative 185 17.05% 18 17.65% 
 Far relative 226 20.83% 14 13.73% 
 I dont know 139 12.81% 5 4.90%  
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 C. Percentage of correct knowledge responses for public and patients: Table-3 
  Public 
responses 
Patient 
responses 
1 Car accidents mainly caused by environmental factors  88.2% 75.5% 
2 Eye color is entirely determined by a person’s genes 81.8% 68.6% 
3 Measles mainly caused by environmental factor  52.7% 64.7% 
4 A daughter of a women with faulty breast cancer gene 
has 50% risk of transmit it. 
50.7% 40.2% 
5 Sickle cell anemia caused by genetic factors 49% 42.2% 
6 Mother with two daughters has breast cancer, there is 
equal chance to pass the faulty gene to each one of 
them. 
46.5% 36.3% 
7 Gene test must be repeated every year as the results 
may change with age 
45.7% 20.6% 
8 Lung cancer caused by environmental and genetic 
factors 
45.2% 29.4% 
9 Strokes caused by both environmental and genetic 
factors  
45.0% 24.8% 
10 Genetic tests are always 100% accurate  44.3% 27.5% 
11 Breast cancer caused by environmental and genetic 
factors 
43.9% 37.3% 
12 Down syndrome caused by genetic factors 41.2% 21.6% 
13 G6PD caused mainly caused by genetic factors 35.4% 27.5% 
14 Father can pass down a faulty breast cancer gene to his 
daughter 
32.4% 15.7% 
15 Spina bifida caused by environmental and genetic 
factors 
13.4% 6.9% 
 
